Uncategorized
BioTime, Inc. to Host Conference Call to Update Investors on Recent Accomplishments and Corporate Objectives for 2016
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today announced that it will host a conference call on Thursday, March 31, to update investors on the Company’s recent accomplishments and objectives for the remainder of 2016. Among the highlights of the call will be an update on the clinical trials currently underway for Renevia® for lipoatrophy, and OpRegen® for dry age-related macular degeneration. In addition, management will discuss recent developments for its other clinical s
